Acadia and ArQule to target GPCRs

Acadia (San Diego, Calif.) and ARQL will identify and develop small molecules targeting G protein-coupled receptors (GPCRs) using Acadia's R-SAT (Receptor Selection and Amplification Technology) cell-...